| Literature DB >> 33421110 |
Yutaro Uchida1, Takahide Matsushima1, Ryota Kurimoto1, Tomoki Chiba1, Yuki Inutani1, Hiroshi Asahara1,2.
Abstract
Programmed death-ligand 1 (PD-L1) is a co-inhibitory molecule expressed on tumor cells. Immune checkpoint inhibitors focusing on the PD-L1 mechanism are now being studied for the treatment of various cancer types. However, the regulatory mechanism of PD-L1 is yet to be fully clarified, and a high-throughput system for comparing the abilities of small compounds in regulating PD-L1 has not yet been established. Therefore, we created a HiBiT-tagged lung adenocarcinoma cell line, PC9-KI, for easier and faster detection of changes in PD-L1 protein expression. Using PC9-KI cells, we screened 1280 chemical compounds from the Library of Pharmacologically Active Compounds and identified microtubule polymerization inhibitors and thapsigargin as PD-L1 upregulators and a p97 inhibitor as a PD-L1 downregulator.Entities:
Keywords: HiBiT; PD-L1; chemical compound; endogenous protein; high-throughput screening
Mesh:
Substances:
Year: 2021 PMID: 33421110 PMCID: PMC7940577 DOI: 10.1002/1873-3468.14032
Source DB: PubMed Journal: FEBS Lett ISSN: 0014-5793 Impact factor: 4.124